Zai Lab Ltd Topline POC Data Readout of ZL-1102 Corporate Call Transcript
Good day, and thank you for standing by. Welcome to the top line POC data readout of ZL-1102. (Operator Instructions) For participants who dialed into the teleconference, you can access the slides via webcast link posted on the company IR's site. (Operator Instructions) And please be advised that today's conference is being recorded. (Operator Instructions)
Now I'd like to hand the conference over to your first speaker for today, Mr. Billy Cho. Please go ahead.
Good morning, ladies and gentlemen. I'm Billy Cho, Chief Financial Officer of Zai Lab. We are holding this conference call to share exciting news about our early development candidate, ZL-1102. And Dr. Reinhart, Chief Medical Officer at Zai Lab for the Autoimmune and Infectious Diseases Therapeutic Areas, will make a brief presentation and then take your questions.
Turn to Slide 2, please. As a reminder, during today's call, Zai Lab will be making certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |